Global Oncology nutrition Market Overview:
Nutrition therapy which is used to help cancer patients to maintain strength, keeps a healthy body weight, keeps body tissue healthy, as well as decreases side effects both during and after treatment is known as Oncology Nutrition. Cancer treatments and the Cancer might affect human sensations including smell, taste, appetite, as well as minimizes the ability to eat and digest enough food or absorb the nutrients from food. These affects can cause malnutrition, which is a condition caused by a lack of key nutrients. Nutrition is a process to take food inside the human body and used by the body for growth and to keep the body healthy. Some of the key players profiled in the study are Abbott Laboratories (United States), Aceto (United States), B. Braun Melsungen AG (Germany), Baxter International (United States), BioSig Technologies (United States), Danone (France), FMC Corporation (United States), Fresenius Kabi AG (Germany), Global Health Products (United States) and Hansen Medical (United States). According to Market Analyst at AMA, the Global Oncology nutrition market may see a growth rate of 8.2% and would reach the market size of USD3.1 Billion by 2024.
On the basis of geography, the market of Oncology nutrition has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Demography, the sub-segment i.e. Infants will boost the Oncology nutrition market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Cancer Type, the sub-segment i.e. Blood will boost the Oncology nutrition market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increasing Prevalence of Cancer
- Rising Demand for the Nutritional Food
- Growing Instances of Extreme Weight Loss in Cancer Patients
- Increasing Demand in Homecare Sector
- Continues Product Innovations
- Side Effects of Few Oncology Nutrients may Hamper Business Growth
- Up surging Nutritional Interventions and Rapid Product Innovations
- Enhancements in Clinical Research and Nutritional Food Product Developments
- Complications Related to Tube Feeding
- Lack of Government Assistance in Generating Reimbursements
Major Market Developments:
On October 10th, 2018, the American Society for Parenteral and Enteral Nutrition (ASPEN), an organization which drives the science and practice of clinical nutrition, and Baxter International Inc., a global leader in clinical nutrition, launched an educational video series on the appropriate use of parenteral nutrition (PN), as part of the organizations’ “SmartPN” collaboration to help reduce clinical malnutrition.
On October 25th, 2018, U.S. Food and Drug Administration (FDA) has cleared Abbott’s next-generation Influenza A and B2 and Strep A2 molecular assays for point-of-care testing. These new assays enable the three time fastest molecular influenza. Both the assays have been granted a Clinical Laboratory Improvement Amendments (CLIA) certificate of waiver which are currently available on the ID NOW platform (formerly known as “Alere I”).
Oncology Nutrition Providers, Manufacturers and Vendors of Enteral Feeding Formulas, Research Associations Related to Enteral Nutrition and Oncology, Hospitals, Nursing Homes, and LTC Facilities, Various Research and Consulting Firms, Government Regulatory Bodies, Hospitals and Clinics and Others
Major Objectives Focused through this Study
To define, describe, and forecast the Global Oncology nutrition market on the basis of product  , application , key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Oncology nutrition market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Oncology nutrition industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Available Customization: Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Vendors which are also part of the research are Hormel Foods (United States), Mead Johnson Nutrition Company (United States), Meiji Holdings Co. Ltd. (Japan), Nestle S.A. (Switzerland) and Victus (United States).
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Oncology nutrition market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.